Error and bias in the evaluation of prescription opioid misuse: Should the FDA regulate clinical assessment tools?

Pain Medicine (United States)

Volumn 14, Issue 7, 2013, Pages 982-987

  Meltzer, Ellen C ^a   Hall, Wayne D ^b   Fins, Joseph J ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Clinical Assessment Tool; Diagnosing Prescription Opioid Addiction; Ethics; Federal Regulation; Prescription Opioid Monitoring

Indexed keywords

ARTICLE; CLINICAL ASSESSMENT TOOL; CLINICAL PRACTICE; DRUG ABUSE; DRUG MISUSE; FOOD AND DRUG ADMINISTRATION; HUMAN; MEDICAL ERROR; MORTALITY; PALLIATIVE THERAPY; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY;

EID: 84880615135     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/pme.12099     Document Type: Review

References (34)

1. Chou R, Fanciullo GJ, Fine PG, etal. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain 2009;10:113-130.
2. Substance Abuse and Mental Health Services Administration (SAMHSA). National Survey on Drug Use and Health. Substance Abuse and Mental Health Services Administration (SAMHSA), 2008.
3. Hall WD, Farrell MP. Minimising the misuse of oxycodone and other pharmaceutical opioids in Australia. Med J Aust 2011;195:248-249.
4. Fletcher RH, Fletcher SW. Clinical Epidemiology the Essentials, 4th edition. Baltimore: Lippincott Williams & Wilkins; 2005.
5. Portenoy RK. Opioid therapy for chronic nonmalignant pain: A review of the critical issues. J Pain Symptom Manage 1996;11:203-217.
6. Butler SF, Budman SH, Fernandez K, Jamison RN. Validation of a screener and opioid assessment measure for patients with chronic pain. Pain 2004;112:65-75.
7. Compton P, Darakjian J, Miotto K. Screening for addiction in patients with chronic pain and "problematic" substance use: Evaluation of a pilot assessment tool. J Pain Symptom Manage 1998;16:355-363.
8. Butler SF, Budman SH, Fernandez KC, etal. Development and validation of the Current Opioid Misuse Measure. Pain 2007;130:144-156.
9. Meltzer EC, Rybin D, Saitz R, etal. Identifying prescription opioid use disorder in primary care: Diagnostic characteristics of the Current Opioid Misuse Measure (COMM). Pain 2011;152:397-402.
10. Christo PJ, Manchikanti L, Ruan X, etal. Urine drug testing in chronic pain. Pain Physician 2011;14:123-143.
11. Pesce A, West C, Egan City K, Strickland J. Interpretation of urine drug testing in pain patients. Pain Med 2012;13:868-885.
12. Liebschutz JM, Saitz R, Weiss RD, etal. Clinical factors associated with prescription drug use disorder in urban primary care patients with chronic pain. J Pain 2010;11:1047-1055.
13. Michna E, Ross EL, Hynes WL, etal. Predicting aberrant drug behavior in patients treated for chronic pain: Importance of abuse history. J Pain Symptom Manage 2004;28:250-258.
14. Wasan AD, Butler SF, Budman SH, etal. Does report of craving opioid medication predict aberrant drug behavior among chronic pain patients? Clin J Pain 2009;25:193-198.
15. Portenoy RK. Opioid therapy for chronic nonmalignant pain: Clinician's perspective. J Law Med Ethics 1996;24:296-309.
16. Solanki DR, Koyyalagunta D, Shah RV, Silverman SM, Manchikanti L. Monitoring opioid adherence in chronic pain patients: Assessment of risk of substance misuse. Pain Physician 2011;14:E119-131.
17. Chou R, Fanciullo GJ, Fine PG, etal. Opioids for chronic noncancer pain: Prediction and identification of aberrant drug-related behaviors: A review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. J Pain 2009;10:131-146.
18. Moore TM, Jones T, Browder JH, Daffron S, Passik SD. A comparison of common screening methods for predicting aberrant drug-related behavior among patients receiving opioids for chronic pain management. Pain Med 2009;10:1426-1433.
19. Liebschutz JM, Alford DP. Safe opioid prescribing: A long way to go. J Gen Intern Med 2011;26:951-952.
20. Passik SD, Kirsh KL. Addiction in pain management. In: McCarberg BH, Passik SD, eds. Expert Guide to Pain Management. Philadelphia: American College of Physicians; 2005:291-298.
21. Greiner M, Pfeiffer D, Smith RD. Principles and practical application of the receiver-operating characteristic analysis for diagnostic tests. Prev Vet Med 2000;45:23-41.
22. U.S. Food and Drug Administration. Clinical Laboratory Improvement Amendments (CLIA). Silver Spring (MD): U.S. Food and Drug Administration, 2009.
23. U.S. Food and Drug Administration. Overview of IVD regulation. Silver Spring (MD): U.S. Food and Drug Administration, 2010.
24. U.S. Food and Drug Administration. How to report a problem (medical devices). Silver Spring (MD): U.S. Food and Drug Administration, 2009.
25. American Psychiatric Association, Task Force on DSM-IV. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR), 4th text revision edition. Washington, DC: American Psychiatric Association; 2000.
26. Spitzer RL, Williams JB, Gibbon M, First MB. The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. Arch Gen Psychiatry 1992;49:624-629.
27. World Health Organization. Composite International Diagnostic Interview (CIDI): Version 2.1. Geneva: World Health Organization; 1997.
28. Meltzer EC, Rybin D, Meshesha LZ, etal. Aberrant drug-related behaviors: Unsystematic documentation does not identify prescription drug use disorder. Pain Med 2012;13:1436-1443.
29. Beck AT. A systematic investigation of depression. Compr Psychiatry 1961;2:163-170.
30. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-571.
31. Fins JJ. Acts of omission and commission in pain management: The ethics of naloxone use. J Pain Symptom Manage 1999;17:120-124.
32. Weissman DE, Haddox JD. Opioid pseudoaddiction-An iatrogenic syndrome. Pain 1989;36:363-366.
33. Institute of Medicine (U.S.). Committee on Crossing the Quality Chasm: Adaptation to Mental Health and Addictive Disorders. Improving the Quality of Health Care for Mental and Substance-Use Conditions. Washington, DC: National Academy Press; 2006.
34. Passik SD, Kirsh KL, Whitcomb L, etal. A new too l to assess and document pain outcomes in chronic pain patients receiving opioid therapy. Clin Ther 2004;26:552-561.